As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
NEW YORK, Oct 20 – For Allison Vecchio, 42, GLP-1 drugs were “a reset button on life,” but…
Kairi Raup Ratusan Juta dari Mahjong Ways 2 di Jam Gacor Ini, Begini Strateginya
Popularitas Mahjong Ways 2 dan Fenomena “Jam Gacor” Kairi, seorang pemain judi daring, baru-baru ini menjadi sorotan setelah…
We asked people taking GLP-1s what happened when their expectations met reality
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.…
MHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on site
Around 8% of children and young people in the UK have a food allergy. Some are at risk…
Launch price of new medicines dropped very slightly in 2025
Amid ongoing angst over prescription drug prices, a new analysis found the median net price for 202 newly…
Warning issued for anyone taking citalopram, fluoxetine and sertraline to prevent ‘future deaths’
Antidepressants in the UK are to carry prominent new “boxed warnings” and patient safety cards. These will highlight…
Indian oncology drug price shakeup: How NPPA price cap on 137 cancer drugs could ease treatment costs
Hyderabad: Patients, hospital chains and the pharmaceutical industry have welcomed the National Pharmaceutical Pricing Authority’s (NPPA) decision to…
Almost 1200 ED presentations linked to unapproved peptide use, figures show
The scale of harm linked to unapproved peptide use has been laid bare, with new figures revealing a…
Would subsidising weight loss drugs make health care fairer?
GLP-1 medicines such as Ozempic, Wegovy and Mounjaro have transformed the treatment of obesity, but access to them…
Disc’s once-spurned rare disease drug to get a second chance at approval
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value?
Praxis Precision Medicines has delivered a very large 3 year share price gain, yet recent pullbacks and a…
MHRA authorises plozasiran (Redemplo) for adults with familial chylomicronaemia syndrome
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 October 2026, authorised plozasiran (Redemplo) to reduce…